Product Information
IVABRADINE HCL 7.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7371 per EA under NDC 62332068060. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
7.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332068060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215238On Market Since
12/20/2024
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 7.5 MG TABLET has been published 67 times since Mar 19, 2025, and over the history we have for it it has declined 83.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7371 per EA |
|---|---|
| All-time high | $4.3323 (Apr 16, 2025) |
| All-time low | $0.7371 (Jun 17, 2026) |
| 52-week high | $3.4354 |
| 52-week low | $0.7371 |
| Median price | $2.5028 |
| Average price | $2.4205 |
| Largest weekly change | -25.7% (Feb 18, 2026) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 7.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.7371 per EA (NDC 62332068060), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 7.5 MG TABLET has declined 83.0%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 7.5 MG TABLET?
Since Mar 19, 2025, the NADAC for IVABRADINE HCL 7.5 MG TABLET has ranged from a low of $0.7371 (Jun 17, 2026) to a high of $4.3323 (Apr 16, 2025), with a median of $2.5028 per EA.
Are there cheaper alternatives to IVABRADINE HCL 7.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IVABRADINE HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 7.5 MG TABLET?
IVABRADINE HCL 7.5 MG TABLET (NDC 62332068060) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification